The device is made of titanium and uses a magnetically levitated rotor to pump blood, replacing both heart ventricles. The artificial heart’s use is being studied as a “bridge-to-heart transplant” for patients with severe heart failure who are waiting for a donor heart, according to an Oct. 11 news release from Banner Health.
The first BiVACOR Total Artificial Heart implantation was performed at Houston-based Texas Heart Institute in July, with the patient receiving a donor heart eight days later.
The second implantation was performed in August at Durham, N.C.-based Duke University Hospital, where the patient received a donor heart 10 days later.
The patient at Banner-University Medical Center Phoenix survived on the artificial heart for “nearly a month” before receiving a donor heart, the release said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
